FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

FDA Information Technology Plan

Federal Register notice: FDA releases its FDA Information Technology Strategy, which is open for comments until 10/30.

latest-news-card-1
Medical Devices

Breakthrough for Parkinsons Neurostimulator

FDA grants InBrain Neuroelectronics a breakthrough device designation for its Intelligent Network Modulation System and its use as an adjunctive thera...

latest-news-card-1
Federal Register

Drug Use-Related Software Guide

Federal Register notice: FDA makes available a draft guidance entitled Regulatory Considerations for Prescription Drug Use-Related Software.

latest-news-card-1
Human Drugs

Kimera Labs Illegally Marketing Exosomes: FDA

FDA warns Miramar, FL-based Kimera Labs about illegally manufacturing and distributing unapproved exosome products that have CGMP deviations.

latest-news-card-1
Medical Devices

CDRH International Harmonization Plan

FDA publishes a draft CDRH strategic plan for medical device international harmonization.

latest-news-card-1
Medical Devices

More 510(k) Changes Likely: Attorneys

Three Ropes & Gray attorneys analyze three FDA draft guidances intended to modernize the 510(k) program, saying they are likely to be precursors to fu...

latest-news-card-1
Federal Register

Guide on Drug Substantial Evidence

Federal Register notice: FDA makes available a draft guidance entitled Demonstrating Substantial Evidence of Effectiveness Based on One Adequate and W...

latest-news-card-1
Medical Devices

FDA Converts ASCA from Pilot to Permanent

FDA says it is converting its medical device Accreditation Scheme for Conformity Assessment from a pilot to a permanent program.

latest-news-card-1
Human Drugs

Houston Man Sentenced in Counterfeit Drugs Case

A federal judge sentences Byron A. Marshall of Houston, TX to 300 months in federal prison for his role in leading a counterfeit drug trafficking sche...

latest-news-card-1
Federal Register

Guide on Drug Substantial Evidence

Federal Register notice: FDA makes available a draft guidance entitled Demonstrating Substantial Evidence of Effectiveness Based on One Adequate and W...